Lung adenocarcinoma (LUAD), the most common form of lung cancer, is already a challenging disease. It is currently the leading cause of cancer death in the United States.¹ In response to therapies that inhibit their genetic drivers, LUAD cells may undergo transformation as a mechanism of resistance and begin to exhibit traits of a more aggressive and difficult-to-treat cancer type known as small cell lung cancer (SCLC). Read more.

Published by The Scientist April 23, 2024

Share this story